Clinical Trials
Learn More
AVAX's International
Subsidiary
Patient information on
AVAX's Phase III
Registration Study MVALDI
Clinical News
AVAX Presents Results of a Dose-Response Study of MVax® at American Society of Clinical Oncology (ASCO)
AVAX Technologies Announces Initiation of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax®)
© 2011 AVAX Technologies, Inc. | Terms
Site design: Schenkel/Stegman